Life Sciences/Biotech

Karmanos Cancer Center Lands $4.7 Million Army Medical Research Grant

DETROIT �?? The Barbara Ann Karmanos Cancer Institute�??s National Oncogenomics and Molecular Imaging Center will soon get a $4,672,000 in federal appropriations from the U.S. Army to help develop technology that will allow for the diagnosis of human cancer by defining oncogene signatures that characterize cancers in individual patients. The federal funding, which will be

By |2008-08-22T00:00:00-04:00August 22nd, 2008|Archive, Life Sciences/Biotech|

New Discovery May Improve Effectiveness Of Cancer Therapies

GRAND RAPIDS - Researchers at Van Andel Institute and Novartis Institutes for Biomedical Research have identified an important enzyme required for cancer cell survival, which could help lead to more effective treatment of pancreatic, prostate and lung cancers. Lowering levels of the enzyme caused a wide variety of cancer cells to die, reduced proliferation of

By |2008-08-19T00:00:00-04:00August 19th, 2008|Archive, Life Sciences/Biotech|

The Michigan Life Sciences Pipeline Adds More Website Resources

TROY - CJPS Enterprises, the operator of the Michigan Life Sciences Pipeline, announced it has posted online more resources for Michigan companies looking for assistance to enter the healthcare market, or to grow their existing healthcare business. This project is dedicated to providing users with information regarding the life sciences. A number of helpful resources,

By |2008-08-18T00:00:00-04:00August 18th, 2008|Archive, Life Sciences/Biotech|

MichBio To Offer Bi-Annual Magazine To Highlight

ANN ARBOR ? Biotech trade association MichBio will publish a bi-annual magazine starting in November devoted to chronicling the discoveries, trends, issues and personalities that are shaping Michigan's biosciences community. "An important part of MichBio's mission is to support our members and the industry as a whole by disseminating materials that inform, educate and assist

By |2008-08-18T00:00:00-04:00August 18th, 2008|Archive, Life Sciences/Biotech|

Embryonic Stem Cell Research Bill Not Change Other State Prohibitions

LANSING - The Michigan Board of State Canvassers was urged by opponents of embryonic stem cell research to point out on ballot language that proposal would effectively allow for a market in embryos and cut state government out of any regulations on embryonic research, while supporters said the proposal is narrowly written to limit the

By |2008-08-12T00:00:00-04:00August 12th, 2008|Archive, Life Sciences/Biotech|

Critical Path Consortium Identifies 7 Tests To Monitor Drug Effects On Kidneys

GRAND RAPIDS - The Critical Path Institute Predictive Safety Testing Consortium, which includes Grand Rapids-based ClinXus, has identified seven new tests to assess the safety of new drugs in development, specifically to monitor the drugs' effects on the kidneys. The U.S. Food and Drug Administration and its equivalent in Europe, the European Medicines Agency, recently

By |2008-08-05T00:00:00-04:00August 5th, 2008|Archive, Life Sciences/Biotech|

West Michigan Science & Tech Initiative Renames Membership Group

GRAND RAPIDS - The West Michigan Science & Technology Initiative has expanded its membership program previously known as BioTech Connect. Now it's called Connect2, a collection of more than 100 companies, corporations and organizations. WMSTI officials said the new name was selected to better reflect the wide range of industries served by the program, and

By |2008-08-05T00:00:00-04:00August 5th, 2008|Archive, Life Sciences/Biotech|

MichBio Announces Program For 2008 Expo

ANN ARBOR - Bioscience trade association MichBio announced details for its 2008 Expo and Conference at the Rock Financial ShowPlace in Novi this November. "This year's Expo provides a robust schedule of offerings covering two full days for the first time," said MichBio Executive Director, Stephen Rapundalo, Ph.D. "We have a number of new programs

By |2008-07-31T00:00:00-04:00July 31st, 2008|Archive, Life Sciences/Biotech|

Van Andel Institute Discovery Aids Drug Developers

GRAND RAPIDS - Researchers in the Laboratory of Structural Sciences at Van Andel Institute have determined how the parathyroid hormone, which is currently used to treat osteoporosis, precisely binds to its receptor. Drug developers can use this information to aid in the design of more potent therapies for osteoporosis that lack the undesired side effects

By |2008-07-31T00:00:00-04:00July 31st, 2008|Archive, Life Sciences/Biotech|